prostate/breast/colon cancer vaccine (CEL-SCI (MaxPharma))

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameprostate/breast/colon cancer vaccine (CEL-SCI (MaxPharma))
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsProstatic NeoplasmsColonic NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCel-Sci Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMaxPharmaCel-Sci Corp
Active IndicationsN/A
Inactive IndicationsProstatic NeoplasmsColonic NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A